Duan, J., Cui, L., Zhao, X., Bai, H., Cai, S., Wang, G., . . . Wang, J. (2020). Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. JAMA Oncol.
Stile di citazione ChicagoDuan, Jianchun, et al. "Use of Immunotherapy With Programmed Cell Death 1 Vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis." JAMA Oncol 2020.
Citazione MLADuan, Jianchun, et al. "Use of Immunotherapy With Programmed Cell Death 1 Vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis." JAMA Oncol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.